Skin and salivary gland carcinogenicity of 7,12-dimethylbenz[a]anthracene is equivalent in the presence or absence of aryl hydrocarbon receptor

Cancer Letters

Volumn 214, Issue 1, 2004, Pages 35-41

  Ide, Fumio ^a   Suka, Noriyuki ^a   Kitada, Munenori ^a   Sakashita, Hideaki ^a   Kusama, Kaoru ^a   Ishikawa, Takatoshi ^b  

^a MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

7,12 Dimethylbenz a anthracene; AhR, aryl hydrocarbon receptor; Aryl hydrocarbon receptor; CYP, cytochrome P450; CYP1B1; DMBA, 7,12 dimethylbenz a anthracene; Epoxide hydrolase; PAH, polycyclic aromatic hydrocarbon; Skin and salivary gland cancer

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; EPOXIDE HYDROLASE; MESSENGER RNA;

ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CARCINOGENICITY; CONTROLLED STUDY; FEMALE; FREQUENCY ANALYSIS; KNOCKOUT MOUSE; LATENT PERIOD; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SKIN CULTURE; STATISTICAL ANALYSIS; SUBMANDIBULAR GLAND;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; BENZ(A)ANTHRACENES; CELL TRANSFORMATION, NEOPLASTIC; CYTOCHROME P-450 CYP1A2; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; RECEPTORS, ARYL HYDROCARBON; RNA, MESSENGER; SALIVARY GLAND NEOPLASMS; SKIN NEOPLASMS;

ANIMALIA;

EID: 4344561188     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.04.014     Document Type: Article

References (36)

1. IARC. Polynuclear Aromatic Hydrocarbons. Part 1: Chemical, Environmental and Experimental Data. 1983;IARC Scientific Publications, IARC, Lyon
2. Ide F., Kitada M., Sakashita H., Kusama K. Reduction of p53 dosage renders mice hypersensitive to 7,12-dimethylbenz[a]anthracene-induced salivary gland tumorigenesis. Anticancer Res. 22:2003;201-204
3. Gonzalez F.J., Fernandez-Salguero P. The aryl hydrocarbon receptor. Studies using the AHR-null mice. Drug. Metab. Dispos. 26:1998;1194-1198
4. Nebert D.W., Roe A.L., Dieter M.Z., Solis W.A., Yang S.Y., Dalton T.P. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem. Pharmacol. 59:2000;65-85
5. Gonzalez F.J., Kimura S. Study of P450 function using gene knockout and transgenic mice. Arch. Biochem. Biophys. 409:2003;153-158
6. Mimura J., Yamashita K., Nakamura K., Morita M., Takagi T.N., Nakao K., et al. Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells. 2:1997;645-654
7. Shimizu Y., Nakatsuru Y., Ichinose M., Takahashi Y., Kume H., Mimura J., et al. Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc. Natl Acad. Sci. USA. 97:2000;779-782
8. Nakatsuru Y., Wakabayashi K., Fujii-Kuriyama Y., Ishikawa T., Kusama K., Ide F. Dibenzo[a,l]pyrene-induced genotoxic and carcinogenic responses are dramatically suppressed in aryl hydrocarbon receptor-deficient mice. Int. J. Cancer. 2004;. in press
9. Cannady E.A., Dyer C.A., Christian P.J., Sipes I.G., Hoyer P.B. Expression and activity of microsomal epoxide hydrolase in follicles isolated from mouse ovaries. Toxicol. Sci. 68:2002;24-31
10. Nelson D.R., Koymans L., Kamataki T., Stegeman J.J., Feyereisen R., Waxman D.J., et al. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics. 6:1996;1-42
11. Miyata M., Kudo G., Lee Y.-H., Yang T.J., Gelboin H.V., Fernandez-Salguero P., et al. Targeted disruption of the microsomal epoxide hydrolase gene. Microsomal epoxide hydrolase is required for the carcinogenic activity of 7,12-dimethylbenz[a]anthracene. J. Biol. Chem. 274:1999;23963-23968
12. Shimada T., Fujii-Kuriyama Y. Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochrome P450 1A1 and 1B1. Cancer Sci. 95:2004;1-6
13. Watabe T., Ishizuka T., Isobe M., Ozawa N. A 7-hydroxymethyl sulfate ester as an active metabolite of 7,12-dimethylbenz[a]anthracene. Science. 215:1982;403-404
14. Watabe T., Ishizuka T., Fujieda T., Hiratsuka A., Ogura K. Sulfate esters of hydroxymethyl-methyl-benz[a]anthracenes as active metabolites of 7,12-dimethylbenz[a]anthracene. Jpn. J. Cancer Res. 76:1985;684-698
15. Buters J., Quintanilla-Martinez L., Schober W., Soballa V.J., Hintermair J., Wolff T., et al. CYP1B1 determines susceptibility to low doses of 7,12-dimethylbenz[a]anthracene-induced ovarian cancers in mice: correlation of CYP1B1-mediated DNA adducts with carcinogenicity. Carcinogenesis. 24:2003;327-334
16. Sutter T.R., Tang Y.M., Hayes C.L., Wo Y.-Y.P., Jabs E.W., Li X., et al. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J. Biol. Chem. 269:1994;13092-13099
17. Buters J.T.M., Sasaki S., Richter T., Pineau T., Alexander D.L., Savas U., et al. Cytochrome P450 CYP1B1 determines susceptibility to 7,12-dimethylbenz[a]anthracene-induced lymphomas. Proc. Natl Acad. Sci. USA. 96:1999;1977-1982
18. Guengerich F.P., Chun Y.-J., Kim D., Gillam E.M., Shimada T. Cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies. Mutat. Res. 523-524:2003;173-182
19. Murray G.I., Melvin W.T., Greenlee W.F., Burke M.D. Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1. Annu. Rev. Pharmacol. Toxicol. 41:2001;297-316
20. Alexander D.L., Eltom S.E., Jefcoate C.R. Ah receptor regulation of CYP1B1 expression in primary mouse embryo-derived cells. Cancer Res. 57:1997;4498-4506
21. Bhattacharyya K.K., Brake P.B., Eltom S.E., Otto S.A., Jefcoate C.R. Identification of a rat adrenal cytochrome P450 active in polycyclic hydrocarbon metabolism as rat CYP1B1. Demonstration of a unique tissue-specific pattern of hormonal and aryl hydrocarbon receptor-linked regulation. J. Biol. Chem. 270:1995;11595-11602
22. Savas U., Bhattacharyya K.K., Christou M., Alexander D.L., Jefcoate C.R. Mouse cytochrome P-450EF, representative of a new 1B subfamily of cytochrome P-450s. Cloning, sequence determination, and tissue expression. J. Biol. Chem. 269:1994;14905-14911
23. Choudhary D., Jansson I., Schenkman J.B., Sarfarazi M., Stoilov I. Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. Arch. Biochem. Biophys. 414:2003;91-100
24. Galvan N., Jaskula-Sztul R., MacWilliams P.S., Czuprynski C.J., Jefcoate C.R. Bone marrow cytotoxicity of benzo[a]pyrene is dependent on CYP1B1 but is diminished by Ah receptor-mediated induction of CYP1A1 in liver. Toxicol. Appl. Pharmacol. 193:2003;84-96
25. Heidel S.M., Czuprynski C.J., Jefcoate C.R. Bone marrow stromal cells constitutively express high levels of cytochrome P4501B1 that metabolize 7,12-dimethylbenz[a]anthracene. Mol. Pharmacol. 54:1998;1000-1006
26. Zhang L., Savas U., Alexander D.L., Jefcoate C.R. Characterization of the mouse Cyp1B1 gene. Identification of an enhancer region that directs aryl hydrocarbon receptor-mediated constitutive and induced expression. J. Biol. Chem. 273:1998;5174-5183
27. Brake P.B., Zhang L., Jefcoate C.R. Aryl hydrocarbon receptor regulation of cytochrome P4501B1 in rat mammary fibroblasts: evidence for transcriptional repression by glucocorticoids. Mol. Phamacol. 54:1998;825-833
28. Christou M., Savas U., Schroeder S., Shen X., Thompson T., Gould M.N., et al. Cytochrome CYP1A1 and CYP1B1 in the rat mammary gland: cell-specific expression and regulation by polycyclic aromatic hydrocarbons and hormones. Mol. Cell. Endocrinol. 15:1995;41-50
29. Eltom S.E., Larsen M.C., Jefcoate C.R. Expression of CYP1B1 but not CYP1A1 by primary cultured human mammary stromal fibroblasts constitutively and in response to dioxin exposure: role of the Ah receptor. Carcinogenesis. 19:1998;1437-1444
30. Larsen M.C., Angus W.G.R., Brake P.B., Eltom S.E., Sukow K.A., Jefcoate C.R. Characterization of CYP1B1 and CYP1A1 expression in human mammary epithelial cells: role of the aryl hydrocarbon receptor in polycyclic aromatic hydrocarbon metabolism. Cancer Res. 58:1998;2366-2374
31. Shehin S.E., Stephenson R.O., Greenlee W.F. Transcriptional regulation of the human CYP1B1 gene. Evidence for involvement of aryl hydrocarbon receptor response element in constitutive expression. J. Biol. Chem. 275:2000;6770-6776
32. Hakkola J., Pasanen M., Pelkonen O., Hukkanen J., Evisalmi S., Anttila S., et al. Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligands in human placenta and cultured cells. Carcinogenesis. 18:1997;391-397
33. Spink D.C., Spink B.C., Cao J.Q., DePasquale J.A., Pentecost B.T., Fasco M.J., et al. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Carcinogenesis. 19:1998;291-298
34. Trombino A.F., Near R.I., Matulka R.A., Yang S., Hafer L.J., Toselli P.A., et al. Expression of the aryl hydrocarbon receptor/transcription factor (AhR) and AhR-regulated CYP1 gene transcripts in a rat model of mammary tumorigenesis. Breast Cancer Res. Treat. 63:2000;117-131
35. Qing W.G., Conti C.J., LaBate M., Johnston D., Slaga T.J., MacLeod M.C. Induction of mammary cancer and lymphoma by multiple, low oral doses of 7,12-dimethylbenz[a]anthracene in SENCAR mice. Carcinogenesis. 18:1997;553-559
36. McFadyen M.C., Rooney P.H., Melvin W.T., Murray G.I. Quantitative analysis of the Ah receptor/cytochrome P450 CYP1B1/CYP1A1 signaling pathway. Biochem. Pharmacol. 65:2003;1663-1674